Atlas Trials

Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma

Clinical trial NCT01658007 · TERMINATED

Trial details

NCT number
NCT01658007
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Relapsed Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic LymphomaRefractory Acute Lymphoblastic LeukemiaRefractory Lymphoblastic Lymphoma
Start date
2012-08-01
Primary completion
2017-01-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.